Stay updated on Radiation Doses for Immunotherapy Progression Clinical Trial
Sign up to get notified when there's something new on the Radiation Doses for Immunotherapy Progression Clinical Trial page.

Latest updates to the Radiation Doses for Immunotherapy Progression Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.4.3 and removes Revision: v3.4.2. This is a metadata update that does not alter study details or user-facing functionality.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision label updated to v3.4.2; funding-related operating-status notice removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check40 days agoChange DetectedA site-wide notice about a lapse in government funding and a page revision to v3.4.1 were added. No core study content changes were observed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check47 days agoChange DetectedAdded a 'Show glossary' option and updated the page footer labels to include Last Update Submitted that Met QC Criteria and Last Update Posted. The page revision has been bumped to v3.4.0 and the older labels (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4) were removed.SummaryDifference0.3%

- Check61 days agoChange DetectedRevision label updated to v3.3.4 (previously v3.3.3) on the page footer.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a consolidated 'Locations' section with state listings (Connecticut, New Jersey, New York, Pennsylvania) and removed the prior per-state location subsections.SummaryDifference0.5%

Stay in the know with updates to Radiation Doses for Immunotherapy Progression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiation Doses for Immunotherapy Progression Clinical Trial page.